首页 | 本学科首页   官方微博 | 高级检索  
     


Impact of a drug utilization review program on high‐risk use of prescription controlled substances
Authors:Matthew Daubresse  Patrick P. Gleason  Yi Peng  Nilay D. Shah  Stephen T. Ritter  G. Caleb Alexander
Affiliation:1. Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, , Baltimore, MD, USA;2. Prime Therapeutics, LLC, , Eagan, MN, USA;3. Department of Pharmaceutical Care and Health Systems, University of Minnesota College of Pharmacy, , Minneapolis, MN, USA;4. Mayo Clinic, , Rochester, MN, USA;5. Blue Cross and Blue Shield of Minnesota, , Eagan, MN, USA;6. Department of Medicine, Johns Hopkins Medicine, , Baltimore, MD, USA;7. Department of Pharmacy Practice, University of Illinois at Chicago School of Pharmacy, , Chicago, IL, USA
Abstract:
Keywords:prescription opioids  drug utilization review  pharmacy benefits manager  pharmacoepidemiology
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号